About
Technology
Issues
FAQ
Links
Official Page
BAMM (BRAF Autophagy and MEK Inhibition in Melanoma): A Phase I/II Trial of Dabrafenib, Trametinib, and Hydroxychloroquine in Advanced
BRAFV600
-mutant Melanoma
Distribution of the number of citations over years.
site/software ©
exaly
; All materials licenced under
CC by-SA
.